These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31193994)

  • 1. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction.
    Schroder J; Mygind ND; Frestad D; Michelsen M; Suhrs HE; Bove KB; Gustafsson I; Kastrup J; Prescott E
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100370. PubMed ID: 31193994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms.
    Bove KB; Michelsen MM; Schroder J; Suhrs HE; Bechsgaard DF; Mygind ND; Aziz A; Kastrup J; Gustafsson I; Prescott E
    Open Heart; 2021 Jan; 8(1):. PubMed ID: 33462108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Flintholm Raft K; Frestad D; Michelsen MM; Suhrs HE; Rask AB; Nilsson M; Hermann TS; Prescott E
    J Vasc Res; 2017; 54(5):309-319. PubMed ID: 28942444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
    Michelsen MM; Mygind ND; Pena A; Aziz A; Frestad D; Høst N; Prescott E;
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):411-7. PubMed ID: 27056160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Mygind ND; Michelsen MM; Pena A; Frestad D; Dose N; Aziz A; Faber R; Høst N; Gustafsson I; Hansen PR; Hansen HS; Bairey Merz CN; Kastrup J; Prescott E
    J Am Heart Assoc; 2016 Mar; 5(3):e003064. PubMed ID: 27068634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease.
    Prescott E; Bove KB; Bechsgaard DF; Shafi BH; Lange T; Schroder J; Suhrs HE; Nielsen RL
    JACC Adv; 2023 Mar; 2(2):100264. PubMed ID: 38938306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, non-endothelial dependent coronary microvascular function and diastolic function-Are they linked?
    Suhrs HE; Schroder J; Bové KB; Mygind ND; Frestad D; Michelsen MM; Lange T; Gustafsson I; Kastrup J; Prescott E
    PLoS One; 2020; 15(7):e0236035. PubMed ID: 32673354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
    Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
    Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Schroder J; Michelsen MM; Mygind ND; Suhrs HE; Bove KB; Bechsgaard DF; Aziz A; Gustafsson I; Kastrup J; Prescott E
    Eur Heart J; 2021 Jan; 42(3):228-239. PubMed ID: 33477168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study.
    Kakuta K; Dohi K; Yamamoto T; Fujimoto N; Shimoyama T; Umegae S; Ito M
    J Am Heart Assoc; 2021 May; 10(9):e019125. PubMed ID: 33899514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER study.
    Michelsen MM; Mygind ND; Pena A; Olsen RH; Christensen TE; Ghotbi AA; Hasbak P; Kjaer A; Gustafsson I; Hansen PR; Hansen HS; Høst N; Kastrup J; Prescott E
    Int J Cardiol; 2017 Feb; 228():435-443. PubMed ID: 27870973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease.
    Schroder J; Prescott E
    Front Cardiovasc Med; 2021; 8():723542. PubMed ID: 34778394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular dysfunction is not associated with a history of reproductive risk factors in women with angina pectoris-An iPOWER substudy.
    Suhrs HE; Kristensen AM; Rask AB; Michelsen MM; Frestad D; Mygind ND; Bové K; Prescott E
    Maturitas; 2018 Jan; 107():110-115. PubMed ID: 28807722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease.
    Schroder J; Zethner-Moller R; Bové KB; Mygind ND; Hasbak P; Michelsen MM; Gustafsson I; Kastrup J; Prescott E
    Atherosclerosis; 2018 Aug; 275():319-327. PubMed ID: 29981522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease.
    Radhakrishnan A; Pickup LC; Price AM; Law JP; McGee KC; Fabritz L; Senior R; Steeds RP; Ferro CJ; Townend JN
    BMC Cardiovasc Disord; 2021 Apr; 21(1):211. PubMed ID: 33902440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.
    Kakuta K; Dohi K; Sato Y; Yamanaka T; Kawamura M; Ogura T; Nakamori S; Fujimoto N; Fujii E; Yamada N; Ito M
    J Am Soc Echocardiogr; 2016 Feb; 29(2):173-80. PubMed ID: 26443046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular repolarization alterations in women with angina pectoris and suspected coronary microvascular dysfunction.
    Dose N; Michelsen MM; Mygind ND; Pena A; Ellervik C; Hansen PR; Kanters JK; Prescott E; ; Kastrup J; Gustafsson I; Hansen HS
    J Electrocardiol; 2018; 51(1):15-20. PubMed ID: 28939174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction.
    Suhrs HE; Raft KF; Bové K; Madsbad S; Holst JJ; Zander M; Prescott E
    Int J Cardiol; 2019 May; 283():28-34. PubMed ID: 30773266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.